[HTML] jci.org

[HTML][HTML] Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho… - The Journal of …, 2018 - Am Soc Clin Investig
BACKGROUND. Cytotoxic T lymphocyte–mediated (CTL-mediated) severe cutaneous
adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic …
被引用次数：224 相关文章

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho… - Journal of Clinical …, 2018 - search.proquest.com
Cytotoxic T lymphocyte-mediated (CTL-mediated) severe cutaneous adverse reactions
(SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) …
[PDF] researchgate.net

[PDF][PDF] Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho, SI Hung… - researchgate.net
BACKGROUND. Cytotoxic T lymphocyte–mediated (CTL-mediated) severe cutaneous
adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic …
[PDF] academia.edu

[PDF][PDF] Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho, SI Hung… - academia.edu
BACKGROUND. Cytotoxic T lymphocyte–mediated (CTL-mediated) severe cutaneous
adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic …

Randomized, controlled trial of TNF-[alpha] antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho… - Journal of Clinical …, 2018 - go.gale.com
BACKGROUND. Cytotoxic T lymphocyte-mediated (CTL-mediated) severe cutaneous
adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic …

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho, SI Hung… - 2018 - pubmed.ncbi.nlm.nih.gov
Background Cytotoxic T lymphocyte-mediated (CTL-mediated) severe cutaneous adverse
reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal …

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

CW Wang, LY Yang, CB Chen, HC Ho… - The Journal of …, 2018 - europepmc.org
BACKGROUND: Cytotoxic T lymphocyte-mediated (CTL-mediated) severe cutaneous
adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic …

[引用][C] Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho… - Journal of Clinical …, 2018 - cir.nii.ac.jp
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse
reactions | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索 …
[HTML] nih.gov

[HTML][HTML] Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

CW Wang, LY Yang, CB Chen, HC Ho… - The Journal of …, 2018 - ncbi.nlm.nih.gov
BACKGROUND. Cytotoxic T lymphocyte–mediated (CTL-mediated) severe cutaneous
adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic …

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

CW Wang, LY Yang, CB Chen, HC Ho… - The Journal of …, 2018 - europepmc.org
BACKGROUND: Cytotoxic T lymphocyte-mediated (CTL-mediated) severe cutaneous
adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic …